Rai L., Ravaggi A., Bignotti E., Hollis RL., Garsed DW., Pandey A., Papalois KB., Patel F., Kamel Y., Campo L., Easton A., Nulsen J., Roskams-Hieter B., Artibani M., Wang L., Hussain N., Wang L., Zaarour N., Aggarwal A., Ahmed-Ebbiary A., Al-Deka A., Churchman M., Herrington CS., Ardighieri L., Ferrari F., Yau C., Gourley C., Odicino F., Ahmed AA.

Supplementary Fig. S5. Representative images of an [A] OxC-EMT-high (patient BS137) and [B] OxC-EMT-low (patient BS141) tumour from the validation mIF experiments. [C] Violin plots demonstrating the difference in the abundance of M2 macrophages (CD206+ or CD206+CD163+) and CD8+TRM using immune cell counts normalised against total number of nuclei in each ROI.

Supplementary Figure S5 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions

DOI

Type

Publication Date